Strategies for Secondary AML and Emerging Therapies for AML
In this podcast episode, Sarah M. Tinsley, PhD, APRN, AOCN, discusses management strategies for secondary AML and novel therapies currently in clinical trials for AML.
Decera Clinical Education Oncology Podcast · Sarah M Tinsley PhD APRN AOCN
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this podcast episode, Sarah M. Tinsley, PhD, APRN, AOCN, discusses management strategies for secondary AML and novel therapies currently in clinical trials for AML. Topics include:
- Liposomal cytarabine plus daunorubicin for secondary AML
- An overview of emerging immune-based strategies for AML
- Evidence on immune-based therapies, including agents targeting CD47, TIM3, and bispecific antibodies
Presenter:
Sarah M. Tinsley, PhD, APRN, AOCN
Nurse Practitioner
Courtesy Assistant Professor
Department of Malignant Hematology
Moffitt Cancer Center
University of South Florida
Tampa, Florida
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.